Concepts (77)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Academic Medical Centers | 2 | 2020 | 144 | 1.370 |
Why?
|
| Pancreatitis | 3 | 2020 | 18 | 1.060 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 4 | 2018 | 31 | 1.010 |
Why?
|
| Endosonography | 5 | 2019 | 57 | 0.990 |
Why?
|
| Pancreatectomy | 2 | 2019 | 28 | 0.870 |
Why?
|
| Colonic Polyps | 1 | 2021 | 16 | 0.850 |
Why?
|
| Adenoma | 1 | 2021 | 36 | 0.830 |
Why?
|
| Necrosis | 2 | 2020 | 53 | 0.740 |
Why?
|
| Stents | 5 | 2020 | 170 | 0.730 |
Why?
|
| Drainage | 5 | 2020 | 53 | 0.730 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 206 | 0.710 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2018 | 7 | 0.700 |
Why?
|
| Common Bile Duct | 2 | 2016 | 7 | 0.680 |
Why?
|
| Pancreatitis, Chronic | 1 | 2016 | 8 | 0.590 |
Why?
|
| Duodenostomy | 1 | 2016 | 1 | 0.590 |
Why?
|
| Jaundice, Obstructive | 1 | 2016 | 3 | 0.590 |
Why?
|
| Palliative Care | 1 | 2016 | 47 | 0.560 |
Why?
|
| Hospitalization | 2 | 2020 | 397 | 0.550 |
Why?
|
| Retrospective Studies | 11 | 2022 | 3120 | 0.420 |
Why?
|
| Histamine H2 Antagonists | 1 | 2020 | 2 | 0.410 |
Why?
|
| Proton Pump Inhibitors | 1 | 2020 | 10 | 0.410 |
Why?
|
| Length of Stay | 3 | 2018 | 286 | 0.330 |
Why?
|
| Pancreatic Neoplasms | 3 | 2016 | 130 | 0.320 |
Why?
|
| Humans | 16 | 2022 | 29179 | 0.320 |
Why?
|
| Cohort Studies | 5 | 2020 | 1709 | 0.310 |
Why?
|
| Hospital Mortality | 2 | 2018 | 187 | 0.290 |
Why?
|
| Middle Aged | 10 | 2022 | 11174 | 0.250 |
Why?
|
| Female | 11 | 2022 | 18317 | 0.240 |
Why?
|
| United States | 3 | 2021 | 3636 | 0.230 |
Why?
|
| Esophageal Motility Disorders | 1 | 2022 | 6 | 0.220 |
Why?
|
| Ultrasonography, Interventional | 2 | 2020 | 54 | 0.220 |
Why?
|
| Esophageal Achalasia | 1 | 2022 | 7 | 0.220 |
Why?
|
| Aged | 7 | 2022 | 9607 | 0.220 |
Why?
|
| Colonoscopy | 1 | 2021 | 41 | 0.210 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 47 | 0.210 |
Why?
|
| Treatment Outcome | 5 | 2022 | 3114 | 0.200 |
Why?
|
| Ascites | 1 | 2019 | 14 | 0.180 |
Why?
|
| Male | 9 | 2020 | 18057 | 0.180 |
Why?
|
| Plastics | 1 | 2018 | 2 | 0.180 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2018 | 4 | 0.180 |
Why?
|
| Adult | 6 | 2022 | 8584 | 0.180 |
Why?
|
| Prosthesis Implantation | 1 | 2018 | 34 | 0.180 |
Why?
|
| Postoperative Complications | 2 | 2019 | 678 | 0.140 |
Why?
|
| Adenocarcinoma | 2 | 2016 | 301 | 0.140 |
Why?
|
| Laparoscopy | 1 | 2017 | 169 | 0.140 |
Why?
|
| Pancreatic Ducts | 2 | 2009 | 5 | 0.120 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2021 | 26 | 0.100 |
Why?
|
| Canada | 1 | 2021 | 48 | 0.100 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2021 | 19 | 0.100 |
Why?
|
| Quality of Life | 1 | 2016 | 793 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 3733 | 0.100 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2009 | 16 | 0.090 |
Why?
|
| Catheterization | 1 | 2009 | 60 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 870 | 0.080 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2022 | 3 | 0.060 |
Why?
|
| Metals | 1 | 2019 | 16 | 0.050 |
Why?
|
| Prosthesis Design | 1 | 2018 | 88 | 0.040 |
Why?
|
| Gastric Bypass | 1 | 2017 | 29 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2009 | 2130 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2009 | 1308 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 889 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 1223 | 0.030 |
Why?
|
| Duodenoscopy | 1 | 2009 | 2 | 0.020 |
Why?
|
| Sphincterotomy, Endoscopic | 1 | 2009 | 5 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2009 | 20 | 0.020 |
Why?
|
| Equipment Safety | 1 | 2009 | 20 | 0.020 |
Why?
|
| Radiosurgery | 1 | 2013 | 317 | 0.020 |
Why?
|
| Postoperative Hemorrhage | 1 | 2009 | 38 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 137 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 150 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2009 | 47 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2009 | 50 | 0.020 |
Why?
|
| Equipment Design | 1 | 2009 | 168 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2009 | 457 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 543 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 535 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 788 | 0.020 |
Why?
|